XML 35 R25.htm IDEA: XBRL DOCUMENT
v2.4.0.6

Note 18 - Financial Instruments | 12 Months Ended
--- | ---
Jun. 30, 2012
Financial Instruments Disclosure [Text Block] | (18) Financial Instruments We determine fair value as the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the Company. In addition, the fair value of liabilities includes consideration of non-performance risk including our own credit risk. Each fair value measurement is reported in one of the three levels, determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are: · Level 1 – inputs are based upon unadjusted quoted prices for identical instruments traded in active markets. · Level 2 – inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. · Level 3 – inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques that include option pricing models, discounted cash flow models, and similar techniques. The following section describes the valuation methodologies we use to measure different financial assets and liabilities at fair value. Assets and Liabilities Measured at Fair Value on a Recurring Basis The following table presents our assets and liabilities measured at fair value on a recurring basis at June 30, 2012 (in thousands):
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Balance |
Cash equivalents |  | $ | 95,137 |  |  | $ | - |  |  | $ | - |  |  | $ | 95,137 |
Available-for-sale securities |  |  | - |  |  |  | 9,005 |  |  |  | - |  |  |  | 9,005 |
Total |  | $ | 95,137 |  |  | $ | 9,005 |  |  | $ | - |  |  | $ | 104,142 |
Cash equivalents consist of money market accounts. We use quoted prices in active markets for identical assets or liabilities to determine fair value. At June 30, 2012, $15.4 million of cash equivalents was restricted and is classified as a long-term asset. Available-for-sale securities consist of U.S. municipal bonds with maturities of less than two years. These bonds are rated A/A2 or better by S&P/Moody’s respectively. There were no material gross unrealized gains or losses on available-for-sale securities at June 30, 2012 or June 30, 2011. Additional information on available-for-sale securities balances at June 30 are provided in the following table (in thousands).
|  | Amortized Cost basis |  |  | Fair Value |
2012 |  | $ | 8,862 |  |  | $ | 9,005 |
2011 |  | $ | 12,739 |  |  | $ | 12,909 |
As of June 30, 2012, the contractual maturities of our available-for-sale investments were as follows (in thousands):
|  | Cost |  |  | Estimated Fair Value |
Due in one year or less |  | $ | 6,999 |  |  | $ | 6,862 |
Due after one year through five years |  | $ | 2,130 |  |  | $ | 2,143 |
Proceeds from sales of investments available for sale were $7.2 million in fiscal 2012 and $7.3 million during fiscal 2011, resulting in no material gain or loss in either period. There were no investments that have been in a continuous loss position for more than one year, and there have been no other-than-temporary impairments recognized. Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis We measure certain assets, including our cost and equity method investments, at fair value on a nonrecurring basis. These assets are recognized at fair value when they are deemed to be other-than-temporarily impaired. During the year ended June 30, 2012, we did not record any other-than-temporary impairments on those assets required to be measured at fair value on a nonrecurring basis.

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References No definition available. + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration